Education and Training
- Fellow, Infectious Diseases, Duke University School of Medicine, 2008 - 2010
- Resident, Internal Medicine, Duke University School of Medicine, 2005 - 2008
- M.D., Wake Forest University, 2005
Lodise, Thomas P., Susan L. Rosenkranz, Matthew Finnemeyer, Scott Evans, Matthew Sims, Marcus J. Zervos, C Buddy Creech, et al. “The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)..” Clin Infect Dis, June 3, 2019. https://doi.org/10.1093/cid/ciz460.
Evans, Scott R., Dean Follmann, Ying Liu, Thomas Holland, Sarah B. Doernberg, Nadine Rouphael, Toshimitsu Hamasaki, et al. “Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)..” Clin Infect Dis 68, no. 11 (May 17, 2019): 1961–67. https://doi.org/10.1093/cid/ciy912.
Turner, Nicholas A., Batu K. Sharma-Kuinkel, Stacey A. Maskarinec, Emily M. Eichenberger, Pratik P. Shah, Manuela Carugati, Thomas L. Holland, and Vance G. Fowler. “Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research..” Nat Rev Microbiol 17, no. 4 (April 2019): 203–18. https://doi.org/10.1038/s41579-018-0147-4.
Holland, Thomas L., Henry F. Chambers, Helen W. Boucher, G Ralph Corey, Rebecca Coleman, Bibiana Castaneda-Ruiz, and Vance G. Fowler. “Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults..” Clin Infect Dis 68, no. 5 (February 15, 2019): 865–72. https://doi.org/10.1093/cid/ciy774.
Huang, David B., Sophie Magnet, Stefania De Angelis, Thomas L. Holland, Thomas M. File, Matthew Dryden, G Ralph Corey, Antoni Torres, and Mark H. Wilcox. “Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe..” Diagn Microbiol Infect Dis 93, no. 2 (February 2019): 154–58. https://doi.org/10.1016/j.diagmicrobio.2018.09.002.
Radovanovic, Dejan, Giovanni Sotgiu, Mateja Jankovic, Padukudru Anand Mahesh, Pedro Jorge Marcos, Mohamed I. Abdalla, Marta Francesca Di Pasquale, et al. “An international perspective on hospitalized patients with viral community-acquired pneumonia..” Eur J Intern Med 60 (February 2019): 54–70. https://doi.org/10.1016/j.ejim.2018.10.020.
Corneli, Amy, Brian Perry, Deborah Collyar, John H. Powers, John J. Farley, Sara B. Calvert, Jonas Santiago, et al. “Assessment of the Perceived Acceptability of an Early Enrollment Strategy Using Advance Consent in Health Care-Associated Pneumonia..” Jama Netw Open 1, no. 8 (December 7, 2018). https://doi.org/10.1001/jamanetworkopen.2018.5816.
Doernberg, Sarah B., Thuy Tien Tram Tran, Steven Y. C. Tong, Mical Paul, Dafna Yahav, Joshua S. Davis, Leonard Leibovici, et al. “Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection..” Clin Infect Dis, October 12, 2018. https://doi.org/10.1093/cid/ciy766.
Holland, Thomas L., Issam Raad, Helen W. Boucher, Deverick J. Anderson, Sara E. Cosgrove, P Suzanne Aycock, John W. Baddley, et al. “Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial..” Jama 320, no. 12 (September 25, 2018): 1249–58. https://doi.org/10.1001/jama.2018.13155.
Huang, David B., G Ralph Corey, Thomas L. Holland, Thomas Lodise, William O’Riordan, Mark H. Wilcox, Thomas M. File, et al. “Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections..” Int J Antimicrob Agents 52, no. 2 (August 2018): 233–40. https://doi.org/10.1016/j.ijantimicag.2018.05.012.